LOS ANGELES, June 11, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ: GDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between September 23, 2020 and November 8, 2022, inclusive (the “Class ...

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the “Class Period”), of the important June 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased GoodRx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

RADNOR, Pa., June 10, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). This action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was filed ...

NEW YORK, June 10, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX). Shareholders who purchased shares of GDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/goodrx-loss-submission-form/?id=83243&from=4 CLASS PERIOD: September 23, 2022 to ...

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX). Shareholders who purchased shares of GDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/goodrx-loss-submission-form/?id=82883&from=3 CLASS PERIOD: September 23, 202 ...

NEW YORK, June 6, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) and reminds investors of the June 21, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In GoodR ...

RADNOR, Pa., June 5, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). This action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was filed i ...

SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired GoodRx Holdings, Inc. (NASDAQ: GDRX) securities between September 23, 2020 and November 8, 2022. GoodRx operates a price comparison platform for prescription drugs which, in many cases, offers consumers access to lower prices (through discount codes and coupons) for their medications. For more information, submit a form, ...

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) and reminds investors of the June 21, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In ...

文章核心观点 - GoodRx Holdings, Inc.是一家提供处方药优惠券的公司,其主要收入来源是处方交易收入 [1][7] - 2022年5月,公司宣布其2022财年指引将受到一家连锁超市的影响,预计将损失约3000万美元收入 [3] - 2022年11月,公司进一步披露该影响将持续到第四季度,预计将损失4500万至5000万美元收入 [5] - 公司此前未能充分披露该连锁超市对公司收入的重要性,导致投资者受到误导 [7] 公司相关 - GoodRx是一家提供处方药优惠券的公司,其主要收入来源是处方交易收入 [1][7] - 公司在2020年9月23日至2022年11月8日期间的股票表现受到负面影响 [1][4][6] - 公司未能充分披露一家连锁超市对其收入的重要性,导致投资者受到误导 [7] 行业相关 - 公司的主要收入来源是处方交易收入,受到连锁超市的影响 [3][5][7] - 公司未能充分披露行业内一家重要客户的情况,导致投资者受到误导 [7]